KOR

e-Article

Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in
Document Type
Article
Source
In: The Lancet Oncology. (The Lancet Oncology, September 2020, 21(9):1213-1223)
Subject
Language
English
ISSN
14745488
14702045